Biotechnology

About Agroindustry

Japan has a severe shortage of arable land, covering only 11.3% of Japan’s total territory. The country’s self-sufficiency rate currently stands at 39%.

About Biotechnology

With an ever-increasing number of bio-ventures and the establishment of a new ecosystem in the Japanese biotech field, this sector offers many opportunities for European SME companies.

Bioinformatics

With Asia’s largest bioinformatics database located in Japan, the sector will be of an increasing importance, especially with its application to the medical and pharmaceutical industries.

BioJapan

BioJapan is Asia’s premier partnering event for the international biotechnology industr

Biopharmaceuticals

Japan is the third largest pharmaceutical market in the world, and the biologically active substances (biopharmaceuticals) are considered to be the driving force behind innovation in this industry.

Biotechnology in Agriculture

In 2020, the Japanese agricultural biotechnology market was valued at about 615 billion yen. Japan remains one of the world’s largest per-capita importers of food and feed produced using modern biotechnologies.

Call for the Next Biotech Mission in Japan

Only a few weeks left to apply for the next Biotech training mission in Japan!

Case Study: HealthCapital: A German Cluster

HEALTHCAPITAL - from DE

HealthCapital Berlin-Brandenburg is the principal healthcare sec

Case Study: OcellO / SME / Search for Additional Partners in Japan

OcellO – from NL

OcellO B.V. was founded in 2011 in Leiden.

Case Study: Protobios Ltd. / SME

Protobios – from EE

Protobios Ltd. was founded in 2003.

Report: Biotech Cluster Mapping and Industry Landscape

This report provides an overview of the bio cluster landscape in Japan.

Report: Biotechnology Market in Japan

This report presents an overview of the Biotechnology market in Japan.

Report: Biotechnology-related Food and Agricultural Products in Japan

About the Report

This report provides an overview of the agricultural biotechnology sect

Report: Cell technology, cell therapy, tissue engineering and gene therapy in Japan

This report is primarily concerned with developments, market trends and regulations within the Japanese cell technology, cell therapy, tissue engineering and gene therapy sectors.

Report: Japan Bioventures Landscape

The report intends to be a useful source of information for European SMEs and clusters considering potential cooperation with Japan.

Report: Japanese competence centers in bioinformatics and computational biology

This report provides an overview of the Japanese competence centers in bioinformatics and computational biology.

Report: Latest trends in biotechnology research in Japan

Japan spends consistently over 3% of its GDP on R&D, of which some 70% come from industry. Concerning biotech-related R&D, more than half is directed towards pharmaceutical and medical goals.

Report: The Biopharmaceuticals Sector in Japan

This report aims to map out the current state of the biopharmaceuticals market in Japan.

Report: The Japanese Model for a Bioeconomy

About the Report:

Report: Update on cell technology, cell therapy, tissue engineering and gene therapy in Japan

This report is an updated edition of a first study on cell technology, cell therapy, tissue engineering and gene therapy in Japan published in 2015.

Only a few weeks left to apply for the next Biotech training mission in Japan!

OcellO – from NL

EU-Japan Centre for Industrial Cooperation